Russell James Bowater

Learn More
CONTEXT While the main focus of a meta-analysis is often to assess the effectiveness of a particular intervention in managing or curing a specific condition, there exists a substantial amount of information within published systematic reviews that could be used to assess the validity of a generic hypothesis about the effectiveness of an intervention across(More)
Despite a large number of clinical trials having been conducted to assess the efficacy of adjuvant chemotherapy after surgery for various cancers, whether it is best to use this treatment remains a generally contentious issue for many common cancers. The purpose of this study was to ascertain whether any general conclusions can be drawn about the efficacy(More)
Systematic reviews and meta-analyses usually synthesise evidence from studies reporting outcomes from particular interventions in specific diseases. For example, a meta-analysis of prophylactic antibiotics (intervention) in elective arterial reconstruction (disease) for rates of wound infection (outcome). However, because systematic reviews and(More)
The aim of this review was to assess the methodological quality of cluster randomised controlled trials (CRCT) for the management of tropical parasitic disease published between 1998 and 2007. A literature survey was conducted using Medline for CRCTs of interventions aimed at managing any one of the six major tropical parasitic diseases: malaria,(More)
CONTEXT A number of authors have found that there exists a positive relationship between progression-free survival and overall survival in clinical trials of cancer treatments for particular types of metastatic cancer. However, such an outcome is consistent with an increase in progression-free survival generally leading to an increase, a decrease or no(More)
BACKGROUND In order to increase the statistical power of a trial design, it is common practice for trialists to place a strong emphasis on end-points other than mortality. To assess the validity of this practice, the aim of this study was to investigate the relationship between the effectiveness of cardiovascular interventions in clinical trials and the(More)
OBJECTIVES In clinical trials of new cancer drugs, reliable data for progression-free survival will often become available far sooner than reliable data for overall survival. The aim of this study was to determine how many months it would be expected that any given new drug for metastatic breast or colorectal cancer will add to overall survival times given(More)
BACKGROUND It is often assumed that differences in the efficacy of treatments between countries (or regions) will be neither negligible nor minor and therefore cannot be overlooked when assessing the potential benefit of treatments in one country (or region) on the basis of trials conducted in another country (or region). AIM To assess differences in the(More)
OBJECTIVE To assess whether there are differences in the results of cardiovascular trials between Europe and Asia using data from an extensive collection of randomised controlled trials. STUDY DESIGN AND SETTING All meta-analyses containing randomised controlled trials (RCT's) for the treatment or prevention of cardiovascular diseases were searched for in(More)
Russell Bowater uses non-additive probability to interpret weighted likelihood. Because I have written a great deal about non-additive probability, the editor has asked me to comment. Non-additive probability goes back to the very beginning of probability theory— the work of Jacob Bernoulli. Bernoulli's calculus for combining arguments allowed both sides of(More)